96 related articles for article (PubMed ID: 18334730)
1. Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer.
Troudi W; Uhrhammer N; Romdhane KB; Sibille C; Amor MB; Khodjet El Khil H; Jalabert T; Mahfoudh W; Chouchane L; Ayed FB; Bignon YJ; Elgaaied AB
Cancer Biomark; 2008; 4(1):11-8. PubMed ID: 18334730
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia.
Troudi W; Uhrhammer N; Sibille C; Dahan C; Mahfoudh W; Bouchlaka Souissi C; Jalabert T; Chouchane L; Bignon YJ; Ben Ayed F; Ben Ammar Elgaaied A
J Hum Genet; 2007; 52(11):915-920. PubMed ID: 17922257
[TBL] [Abstract][Full Text] [Related]
3. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
[TBL] [Abstract][Full Text] [Related]
4. Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.
Mahfoudh W; Bouaouina N; Ahmed SB; Gabbouj S; Shan J; Mathew R; Uhrhammer N; Bignon YJ; Troudi W; Elgaaied AB; Hassen E; Chouchane L
Mol Biol Rep; 2012 Feb; 39(2):1037-46. PubMed ID: 21603858
[TBL] [Abstract][Full Text] [Related]
5. Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia.
Riahi A; Kharrat M; Ghourabi ME; Khomsi F; Gamoudi A; Lariani I; May AE; Rahal K; Chaabouni-Bouhamed H
Clin Genet; 2015 Feb; 87(2):155-60. PubMed ID: 24372583
[TBL] [Abstract][Full Text] [Related]
6. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
7. Complete mutation screening and haplotype characterization of the BRCA1 gene in 61 familial breast cancer patients from Norway.
Frost P; Jugessur A; Apold J; Heimdal K; Aloysius T; Eliassen AK; Fauske L; Matre G; Eiken HG
Dis Markers; 2005; 21(1):29-36. PubMed ID: 15735322
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.
Meindl A;
Int J Cancer; 2002 Feb; 97(4):472-80. PubMed ID: 11802209
[TBL] [Abstract][Full Text] [Related]
9. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B
Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118
[TBL] [Abstract][Full Text] [Related]
10. BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African.
Laraqui A; Uhrhammer N; Rhaffouli HE; Sekhsokh Y; Lahlou-Amine I; Bajjou T; Hilali F; El Baghdadi J; Al Bouzidi A; Bakri Y; Amzazi S; Bignon YJ
Dis Markers; 2015; 2015():194293. PubMed ID: 25814778
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.
Shattuck-Eidens D; Oliphant A; McClure M; McBride C; Gupte J; Rubano T; Pruss D; Tavtigian SV; Teng DH; Adey N; Staebell M; Gumpper K; Lundstrom R; Hulick M; Kelly M; Holmen J; Lingenfelter B; Manley S; Fujimura F; Luce M; Ward B; Cannon-Albright L; Steele L; Offit K; Thomas A
JAMA; 1997 Oct; 278(15):1242-50. PubMed ID: 9333265
[TBL] [Abstract][Full Text] [Related]
12. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
Ikeda N; Miyoshi Y; Yoneda K; Shiba E; Sekihara Y; Kinoshita M; Noguchi S
Int J Cancer; 2001 Jan; 91(1):83-8. PubMed ID: 11149425
[TBL] [Abstract][Full Text] [Related]
13. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
Phelan CM; Kwan E; Jack E; Li S; Morgan C; Aubé J; Hanna D; Narod SA
Hum Mutat; 2002 Nov; 20(5):352-7. PubMed ID: 12402332
[TBL] [Abstract][Full Text] [Related]
14. [Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women].
Mestiri S; Monastiri K; Ben Ahmed S; Bouaouina N; Presneau N; Bignon YJ; Khairi H; Chouchane L
Arch Inst Pasteur Tunis; 2000; 77(1-4):11-5. PubMed ID: 14658222
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history.
Malone KE; Daling JR; Thompson JD; O'Brien CA; Francisco LV; Ostrander EA
JAMA; 1998 Mar; 279(12):922-9. PubMed ID: 9544766
[TBL] [Abstract][Full Text] [Related]
16. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants.
Delgado L; Fernández G; Grotiuz G; Cataldi S; González A; Lluveras N; Heguaburu M; Fresco R; Lens D; Sabini G; Muse IM
Breast Cancer Res Treat; 2011 Jul; 128(1):211-8. PubMed ID: 21190077
[TBL] [Abstract][Full Text] [Related]
18. An identical novel mutation in BRCA1 and a common haplotype in familial ovarian cancer in non-Ashkenazi Jews.
Theodor L; Bar-Sade R; Kruglikova A; Ben-Baruch G; Risel S; Shiri-Sverdlov R; Hirsh Yechezkel G; Modan B; Papa MZ; Rechavi G; Friedman E
Br J Cancer; 1998 Jun; 77(11):1880-3. PubMed ID: 9667663
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
20. Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.
Schorge JO; Mahoney NM; Miller DS; Coleman RL; Muller CY; Euhus DM; Tomlinson GE
Gynecol Oncol; 2001 Nov; 83(2):383-7. PubMed ID: 11606101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
